AMX-268

N/A

Report date: 2026/03/26 20:00:17

Base Information

Drug NameAMX-268
Drug Alias NameEpCAM-targeted T cell engager (Amunix)AMX-268
ClassificationBiologics > T cell engagers
Mechanisms of ActionEpithelial cell adhesion molecule modulators
TargetsEpithelial cell adhesion molecule
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAmunix Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAmunix Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A